Infectious Disease and Microbiology – Mycoplasma Species

Overview

Mycoplasma species are extremely small, pleomorphic bacteria that lack a cell wall. This absence of peptidoglycan is their defining microbiologic feature and explains why β-lactam antibiotics such as penicillins and cephalosporins are ineffective.

Many Mycoplasma species exist as commensal organisms of human mucosal surfaces. Clinically, Mycoplasma pneumoniae is most important as a respiratory pathogen, while M. genitalium and M. hominis are associated primarily with the genitourinary tract.

Classification

Genus: Mycoplasma

Species listed in the source include:

• M. buccale

• M. faucium

• M. felis

• M. genitalium

• M. hominis

• M. laidlawii

• M. lipophilum

• M. oculi

• M. orale

• M. penetrans

• M. pirum

• M. pneumoniae

• M. primatum

• M. salivarium

• M. spermatophilum

• M. urealyticum

Taxonomic Note

The organism historically called:

Mycoplasma urealyticum

is now classified as:

Ureaplasma urealyticum

It shares the important characteristic of lacking a conventional bacterial cell wall.

Microbiologic Characteristics

Mycoplasma species are:

• Very small bacteria

• Without a cell wall

• Pleomorphic

• Surrounded only by a cell membrane

• Poorly visualized by conventional Gram staining

Because there is no rigid peptidoglycan layer, these organisms can assume variable shapes.

The Most Important Feature – No Cell Wall

The absence of a cell wall has major therapeutic implications.

Antibiotics that inhibit cell-wall synthesis have no appropriate target.

Therefore:

Penicillins

• ●

Cephalosporins

• ●

Other β-lactam antibiotics

→ Ineffective against Mycoplasma

High-Yield Microbiology Pattern

Extremely small bacterium

• ●

No cell wall

• ●

Pleomorphic

• ●

Does not stain well with Gram stain

• ●

Intrinsically resistant to β-lactams

→ Think Mycoplasma

Epidemiology

Mycoplasma species occur:

Worldwide

Many are commensal organisms that may be recovered from healthy human mucosal surfaces.

Therefore, isolation of some species does not necessarily establish that they are causing disease.

Major Sites

M. pneumoniae

→ Respiratory tract

M. hominis

→ Genitourinary tract

M. genitalium

→ Genitourinary tract and sexually transmitted infection

Mycoplasma pneumoniae

M. pneumoniae is the major respiratory pathogen in this genus and is a classic cause of:

Atypical pneumonia

It also causes several upper and lower respiratory tract syndromes.

Incubation Period

The source gives an incubation period of:

6–32 days

for clinical syndromes caused by M. pneumoniae.

The relatively long incubation period allows gradual transmission within households and other close-contact populations.

Transmission

M. pneumoniae is transmitted mainly through:

Respiratory droplets

Close and prolonged interpersonal contact facilitates transmission.

Epidemiologic Pattern

Respiratory infection is particularly common among:

Older children, adolescents, and young adults

The source emphasizes patients approximately:

10–40 years old

Infections can occur:

• Sporadically

• Endemically

• In outbreaks or epidemics

Disease occurs throughout the year.

Outbreak Settings

Transmission may be facilitated in:

• Schools

• Dormitories

• Military barracks

• Households

• Other crowded living environments

Respiratory Infections

M. pneumoniae can cause:

• Pneumonia

• Bronchitis

• Tracheobronchitis

• Pharyngitis

• Sinusitis

• Myringitis

Atypical Pneumonia

The classic respiratory syndrome is:

Atypical or “walking” pneumonia

Patients often develop a gradually progressive illness rather than the abrupt presentation typical of some bacterial pneumonias.

Clinical Manifestations

Typical manifestations include:

• Fever

• Malaise

• Headache

• Sore throat

• Persistent dry cough

• Bronchitis

• Pneumonia

The cough can persist for a prolonged period.

High-Yield Respiratory Pattern

Adolescent or young adult

• ●

Gradual respiratory illness

• ●

Persistent dry cough

• ●

Atypical pneumonia

→ Think Mycoplasma pneumoniae

Extrapulmonary Manifestations

Although M. pneumoniae primarily causes respiratory disease, rare extrapulmonary complications include:

• Hemolytic anemia

• Pericarditis

• Myocarditis

• Meningoencephalitis

• Erythema multiforme

• Hepatitis

Some complications may result from immune-mediated mechanisms.

Cold Agglutinin Hemolytic Anemia

A classic association of M. pneumoniae is:

Cold agglutinin-associated hemolytic anemia

Antibodies generated during infection can react with red blood cells at lower temperatures and produce agglutination and hemolysis.

High-Yield Association

M. pneumoniae

→ Cold agglutinins

→ Red-cell agglutination

→ Hemolytic anemia

This is an important exam association, although cold agglutinin testing is neither sufficiently sensitive nor specific to be the preferred modern diagnostic method.

Cardiac Disease

Rare cardiac manifestations include:

Myocarditis

and

Pericarditis

Neurologic Disease

Rare neurologic complications include:

• Encephalitis

• Meningitis

• Meningoencephalitis

Dermatologic Disease

M. pneumoniae may be associated with:

Erythema multiforme

and other mucocutaneous inflammatory syndromes.

Myringitis

M. pneumoniae has historically been associated with:

Bullous myringitis

However, bullous myringitis is not specific for M. pneumoniae and can occur with other respiratory pathogens.

Mycoplasma genitalium

M. genitalium is an important sexually transmitted pathogen.

It is associated with:

• Nongonococcal urethritis

• Persistent or recurrent urethritis

• Cervicitis

• Pelvic inflammatory disease

High-Yield STI Pattern

Sexually active patient

• ●

Persistent/recurrent nongonococcal urethritis

→ Consider Mycoplasma genitalium

Pelvic Inflammatory Disease

M. genitalium can infect the female reproductive tract and has been associated with:

Pelvic inflammatory disease

Persistent reproductive tract infection may potentially contribute to reproductive complications.

Mycoplasma hominis

M. hominis is primarily associated with the:

Genitourinary tract

It may be recovered as part of normal genital flora but can also participate in clinically significant infection.

Salpingitis

The source reports isolation of M. hominis from the:

• Endometrium

• Fallopian tubes

in approximately 10% of women with salpingitis.

However, because salpingitis and pelvic inflammatory disease are frequently:

Polymicrobial

the presence of M. hominis does not necessarily prove that it is the primary pathogen.

Mycoplasma fermentans

The source associates M. fermentans with uncommon reports of:

• Pneumonia

• Encephalitis

• Hepatitis

• Myopericarditis

• Sepsis

• Diarrhea

Its role in human disease is less firmly established than that of M. pneumoniae or M. genitalium.

Infertility

Some studies have suggested possible associations between genital Mycoplasma species and:

Infertility

However, interpretation is complicated because several species can colonize the genital tract without producing disease.

Therefore:

Detection does not automatically equal causation.

Diagnosis

The source lists:

• Culture

• Serology

• Detection of cold agglutinins

• PCR of respiratory specimens for M. pneumoniae

PCR and NAAT

Molecular testing is particularly useful because Mycoplasma organisms can be difficult or slow to culture.

For M. pneumoniae:

PCR/NAAT of respiratory specimens

can provide direct evidence of infection.

For M. genitalium:

NAAT is the major diagnostic approach

because routine culture is extremely difficult.

Culture

Mycoplasma species require specialized culture conditions.

Some species grow slowly, making culture less useful for rapid clinical diagnosis.

Classic Culture Appearance

A traditional microbiologic association is:

“Fried-egg” colonies

on specialized culture media.

Serology

Serology may assist in diagnosing M. pneumoniae infection, particularly when interpreted with the timing and clinical presentation.

Cold Agglutinins

The source lists:

Cryoagglutinin/cold agglutinin testing

for M. pneumoniae.

This is primarily a historical or supportive clue rather than a definitive modern diagnostic test.

Treatment

The source lists:

Doxycycline 100 mg orally every 12 hours for 7–14 days

as treatment.

Other active antibiotic classes include:

• Macrolides

• Fluoroquinolones

The appropriate drug depends on the species, clinical syndrome, patient factors, and resistance patterns.

Treatment of M. pneumoniae

The source lists:

Macrolides

or

Fluoroquinolones

as additional treatments for M. pneumoniae infection.

Doxycycline is another important active agent.

Major Treatment Principle

Because Mycoplasma lacks a cell wall:

β-lactams do NOT work.

This includes:

• Penicillin

• Amoxicillin

• Ampicillin

• Cephalosporins

• Carbapenems

Why β-Lactams Fail

β-lactam

↓

Inhibits peptidoglycan cell-wall synthesis

↓

Mycoplasma has no peptidoglycan cell wall

↓

No therapeutic target

↓

Intrinsic resistance

Mycoplasma genitalium and Resistance

M. genitalium has become particularly important because antimicrobial resistance can complicate treatment.

Resistance may involve:

Macrolides

and

Fluoroquinolones

Therefore, treatment of confirmed M. genitalium infection should follow appropriate current guideline- or resistance-guided regimens rather than assuming that all isolates will respond to the same antibiotic.

Mycoplasma pneumoniae vs. Typical Bacterial Pneumonia

M. pneumoniae

→ No cell wall

→ Atypical pneumonia

→ Gradual onset

→ Dry cough

→ Young patients/outbreak settings

→ Cold agglutinins

→ β-lactams ineffective

Streptococcus pneumoniae

→ Gram-positive diplococcus

→ Cell wall present

→ Typical community-acquired pneumonia

→ More abrupt presentation may occur

→ Productive cough may occur

→ Susceptible infections can respond to β-lactams

Mycoplasma vs. Ureaplasma

Mycoplasma

→ No cell wall

→ M. pneumoniae: respiratory disease

→ M. genitalium: urethritis/PID

→ M. hominis: genitourinary colonization/infection

Ureaplasma

→ Also lacks a cell wall

→ Primarily genitourinary

→ Characteristically hydrolyzes urea

Prevention

For respiratory M. pneumoniae infection, transmission may be reduced through:

• Respiratory hygiene

• Avoidance of prolonged close exposure to infected individuals

• Reduction of crowding when feasible

For sexually transmitted organisms such as M. genitalium:

• Condom use

• Safer sexual practices

• Appropriate evaluation and management of sexual partners

can reduce transmission.

High-Yield Clinical Pattern

Young patient

• ●

“Walking” atypical pneumonia

• ●

Persistent dry cough

• ●

Cold agglutinins

• ●

Organism without a cell wall

→ Think Mycoplasma pneumoniae

High-Yield Genitourinary Pattern

Persistent or recurrent nongonococcal urethritis

• ●

Sexual transmission

• ●

NAAT positive

→ Think Mycoplasma genitalium

Exam Essentials

Genus: Mycoplasma

Defining feature: NO CELL WALL

Morphology: Very small and pleomorphic

Gram stain: Poorly visualized

β-lactams: Intrinsically ineffective

Major respiratory species: M. pneumoniae

Major STI species: M. genitalium

Important genital species: M. hominis

M. pneumoniae incubation: 6–32 days in the source

Transmission: Respiratory droplets

Classic disease: Atypical “walking” pneumonia

Classic symptom: Persistent dry cough

Classic laboratory association: Cold agglutinins

Important complication: Hemolytic anemia

Other complications: Myocarditis, pericarditis, CNS disease, erythema multiforme, hepatitis

M. genitalium: Nongonococcal urethritis, cervicitis, PID

Diagnosis: PCR/NAAT particularly useful

Classic culture appearance: “Fried-egg” colonies

Source treatment: Doxycycline

M. pneumoniae alternatives: Macrolide or fluoroquinolone

Key therapeutic rule: Do not treat Mycoplasma with β-lactam antibiotics

Key clinical pearl: The single most important fact about Mycoplasma is that it has no cell wall, making β-lactam antibiotics ineffective. Remember M. pneumoniae for atypical “walking” pneumonia with a persistent dry cough and cold agglutinins, and M. genitalium for persistent or recurrent nongonococcal urethritis and pelvic inflammatory disease.

Infectious Disease and Microbiology – Mycobacterium bovis

Overview

Mycobacterium bovis is an aerobic, acid-fast bacillus belonging to the Mycobacterium tuberculosis complex (MTBC). It primarily causes tuberculosis in cattle but can infect humans and produce disease that is clinically similar to tuberculosis caused by M. tuberculosis.

Human infection has classically been associated with consumption of unpasteurized dairy products, although transmission can also occur through inhalation of infectious aerosols.

Classification

Genus: Mycobacterium

Species: M. bovis

Complex: Mycobacterium tuberculosis complex

Type: Acid-fast bacillus

Microbiologic Characteristics

M. bovis is:

• Aerobic

• Slender bacillus

• Acid-fast

• Nonmotile

• Non-spore-forming

• Slow-growing

Like other mycobacteria, its cell wall contains large amounts of:

Mycolic acids

which contribute to acid-fast staining and resistance to many environmental stresses.

Acid-Fastness

The lipid-rich cell wall allows M. bovis to retain certain dyes despite acid-alcohol decolorization.

Therefore:

Acid-fast bacillus

• ●

Tuberculosis-like disease

→ Consider organisms within the M. tuberculosis complex

Epidemiology

M. bovis is primarily a:

Zoonotic pathogen

Cattle represent an important reservoir, although infection can occur in several other mammalian species.

Transmission

The classic route of human infection is:

Ingestion of contaminated, unpasteurized milk or dairy products

Another important route is:

Inhalation of infectious respiratory aerosols

particularly in settings involving close exposure to infected animals.

Importance of Pasteurization

Historically, bovine tuberculosis was an important source of human disease through contaminated milk.

Widespread:

Milk pasteurization

• ●

Control of bovine tuberculosis in cattle

have greatly reduced foodborne M. bovis infection in many countries.

Pathogenesis

After entering the body, M. bovis can survive within:

Macrophages

and produce granulomatous disease similar to M. tuberculosis.

The anatomical pattern can partly reflect the route of acquisition.

Route of Infection and Disease Pattern

Ingestion of contaminated dairy products

→ Oropharyngeal or gastrointestinal exposure

→ Regional lymphatic involvement

→ Cervical lymphadenitis or gastrointestinal tuberculosis

Whereas:

Inhalation of infectious aerosols

→ Pulmonary exposure

→ Pulmonary tuberculosis

Lymphadenitis

One important manifestation is:

Tuberculous lymphadenitis

Historically, cervical lymphadenitis associated with bovine tuberculosis was sometimes referred to as:

Scrofula

especially when cervical lymph nodes were involved.

Pulmonary Infection

Aerosol transmission can result in:

Pulmonary tuberculosis

Clinical manifestations may include:

• Persistent cough

• Fever

• Night sweats

• Weight loss

• Fatigue

• Hemoptysis in advanced disease

Pulmonary M. bovis infection may be clinically difficult to distinguish from pulmonary M. tuberculosis infection without microbiologic identification.

Gastrointestinal Infection

Ingestion of contaminated unpasteurized dairy products can produce:

Gastrointestinal tuberculosis

Potential manifestations include:

• Abdominal pain

• Fever

• Weight loss

• Intestinal inflammation

• Regional lymphadenopathy

High-Yield Exposure Pattern

Tuberculosis-like illness

• ●

History of unpasteurized milk or dairy consumption

• ●

Cattle exposure

→ Consider Mycobacterium bovis

Diagnosis

The source lists:

Culture

as the primary diagnostic method.

Culture allows confirmation of mycobacterial infection and can help differentiate organisms within the M. tuberculosis complex.

Additional Diagnostic Methods

Evaluation of suspected disease may include:

• Acid-fast staining

• Mycobacterial culture

• Nucleic acid amplification testing

• Species identification

• Drug susceptibility testing

• Histopathology of affected tissue

Because treatment differs in an important way from standard M. tuberculosis therapy, species-level identification can be clinically significant.

Histopathology

Affected tissues may demonstrate:

Granulomatous inflammation

with:

Caseous necrosis

similar to tuberculosis caused by M. tuberculosis.

Acid-fast bacilli may sometimes be demonstrated within tissue specimens.

Major Drug Resistance Feature

The most important pharmacologic characteristic of M. bovis is:

Intrinsic resistance to pyrazinamide

This is a classic distinction from typical drug-susceptible M. tuberculosis.

High-Yield Resistance Pattern

Tuberculosis

• ●

M. bovis identified

→ Remember:

PYRAZINAMIDE RESISTANT

This is one of the most important exam associations for M. bovis.

Treatment

The source describes treatment using:

Isoniazid (INH)

• ●

Rifampin

• ●

Ethambutol or streptomycin

Because M. bovis is intrinsically resistant to pyrazinamide, pyrazinamide should not be relied upon as an active drug.

Duration

The source states that:

Most infections require 9 months or more of therapy

The longer duration compared with conventional pyrazinamide-containing tuberculosis regimens reflects the absence of pyrazinamide from an effective treatment regimen.

Actual therapy should be determined by susceptibility testing, disease location, severity, and current tuberculosis treatment guidance.

Treatment Principle

M. bovis tuberculosis

↓

Confirm organism and susceptibility

↓

Isoniazid + rifampin + additional active agent initially

↓

Do not count pyrazinamide as active therapy

↓

Continue an appropriately prolonged tuberculosis regimen

M. bovis vs. M. tuberculosis

Mycobacterium bovis

→ Member of M. tuberculosis complex

→ Important animal reservoir, especially cattle

→ Zoonotic

→ Unpasteurized dairy is a classic exposure

→ Can also spread by aerosols

→ Intrinsically resistant to pyrazinamide

Mycobacterium tuberculosis

→ Primarily human reservoir

→ Mainly transmitted through respiratory aerosols

→ Pulmonary disease is classic

→ Usually pyrazinamide susceptible unless acquired resistance occurs

M. bovis and BCG

An important microbiologic connection is the:

BCG vaccine

BCG was developed from an attenuated strain of:

Mycobacterium bovis

Thus:

M. bovis

→ attenuation

→ M. bovis BCG

→ Bacillus Calmette–Guérin vaccine

Prevention

Prevention of human M. bovis infection includes:

• Pasteurization of milk

• Avoidance of unpasteurized dairy products

• Control of bovine tuberculosis

• Veterinary surveillance

• Appropriate precautions when working with potentially infected animals

• Respiratory infection-control measures when infectious pulmonary disease is present

High-Yield Clinical Pattern

Tuberculosis-like disease

• ●

Unpasteurized dairy or cattle exposure

• ●

Lymphadenitis, gastrointestinal disease, or pulmonary infection

• ●

Pyrazinamide resistance

→ Think Mycobacterium bovis

Exam Essentials

Organism: Mycobacterium bovis

Genus: Mycobacterium

Complex: Mycobacterium tuberculosis complex

Type: Aerobic acid-fast bacillus

Reservoir: Primarily cattle and other animals

Disease: Zoonotic tuberculosis

Classic transmission: Unpasteurized milk/dairy products

Other transmission: Respiratory aerosols

Major infections: Lymphadenitis, pulmonary tuberculosis, gastrointestinal tuberculosis

Diagnosis: Mycobacterial culture with species identification; molecular testing may assist

Key resistance: Intrinsic pyrazinamide resistance

Source treatment: INH + rifampin + ethambutol or streptomycin

Treatment duration: Typically prolonged; source describes ≥9 months

Prevention: Milk pasteurization and control of bovine tuberculosis

Vaccine association: BCG is derived from attenuated M. bovis

Key clinical pearl: Mycobacterium bovis is a zoonotic member of the M. tuberculosis complex classically acquired from unpasteurized dairy products or infected cattle. The single most important therapeutic clue is its intrinsic resistance to pyrazinamide, while the classic preventive measure is milk pasteurization.

Infectious Disease and Microbiology – Multiceps multiceps

Overview

Multiceps multiceps is a cestode (tapeworm) helminth primarily associated with dogs. Humans are accidental intermediate hosts and acquire infection by ingesting eggs shed in dog feces.

Human infection is extremely rare but can produce coenurosis, characterized by development of larval cysts within tissues. Involvement of the central nervous system (CNS) is the most clinically important manifestation.

Classification

Genus: Multiceps

Species: M. multiceps

Type: Cestode helminth (tapeworm)

Definitive host: Dogs and other canids

Human role: Accidental intermediate host

Taxonomic Note

Multiceps multiceps has historically been used for this parasite, although it is also commonly classified within the genus Taenia as:

Taenia multiceps

The larval infection produced in intermediate hosts is called:

Coenurosis

Microbiologic Characteristics

M. multiceps is a cestode whose adult form normally inhabits the intestine of its definitive canid host.

The important infectious stage for humans is the:

Egg

After eggs are accidentally ingested, larvae can migrate through tissues and develop into characteristic cystic structures called:

Coenuri

Incubation Period

The incubation period is:

Unknown

Clinical manifestations may not become apparent until a larval cyst has enlarged sufficiently to produce local tissue effects.

Epidemiology

M. multiceps has a:

Worldwide distribution

However, human infection is:

Very rare

The parasite primarily circulates between dogs or other canids and their normal intermediate hosts.

Transmission

Humans acquire infection through:

Ingestion of eggs from dog feces

This can occur through fecal contamination of:

• Hands

• Food

• Water

• Soil

Humans therefore act as accidental hosts rather than being necessary for continuation of the parasite’s normal life cycle.

Life Cycle

Adult tapeworm in dog/canid intestine

↓

Eggs released in feces

↓

Accidental human ingestion of eggs

↓

Larvae penetrate intestinal wall

↓

Hematogenous dissemination

↓

Development of coenurus cyst in tissue

↓

Possible CNS, ocular, subcutaneous, or other tissue disease

Coenurosis

Human infection with the larval stage is called:

Coenurosis

The characteristic lesion is a:

Coenurus cyst

A coenurus differs from some other cestode larval cysts because it can contain:

Multiple protoscolices

within a single cyst.

Central Nervous System Coenurosis

The source particularly emphasizes:

CNS cyst formation

Scattered cases of cerebral coenurosis have been reported in humans.

Clinical Manifestations

Neurologic manifestations depend on the:

• Location of the cyst

• Size of the cyst

• Degree of surrounding inflammation

• Intracranial pressure

Possible manifestations include:

• Headache

• Seizures

• Focal neurologic deficits

• Visual abnormalities

• Symptoms of increased intracranial pressure

High-Yield CNS Pattern

Dog exposure

• ●

Possible fecal contamination

• ●

Cestode larval cyst in CNS

→ Consider Multiceps multiceps coenurosis

Other Forms of Coenurosis

Although CNS disease is particularly important, larval cysts may occasionally involve other tissues, producing:

• Ocular coenurosis

• Subcutaneous coenurosis

• Muscular or other tissue involvement

Clinical manifestations depend on the affected anatomical site.

Diagnosis

The source emphasizes:

Histopathologic examination of surgically removed affected tissue

Identification of characteristic parasitic structures within the cyst can establish the diagnosis.

Histopathology

Examination of an excised cyst may demonstrate:

Coenurus larval structures

with multiple developing protoscolices.

Because infection is rare, definitive diagnosis may require careful parasitologic and histopathologic evaluation.

Imaging

When CNS involvement is suspected, imaging such as:

CT or MRI

can identify cystic lesions and define their:

• Location

• Size

• Number

• Relationship to surrounding structures

Imaging alone may not reliably distinguish coenurosis from other parasitic or nonparasitic cystic lesions.

Differential Diagnosis

CNS coenurosis may need to be distinguished from:

• Neurocysticercosis due to Taenia solium

• Echinococcosis

• Brain abscess

• Primary or metastatic tumors

• Other intracranial cystic lesions

Coenurosis vs. Cysticercosis

Coenurosis – Taenia (Multiceps) multiceps

→ Dogs/canids are definitive hosts

→ Humans ingest eggs from canid fecal contamination

→ Coenurus cyst contains multiple protoscolices

→ CNS, ocular, or subcutaneous disease

Cysticercosis – Taenia solium

→ Humans ingest T. solium eggs

→ Individual cysticercus generally contains one scolex

→ Neurocysticercosis is much more common than human coenurosis

High-Yield Morphologic Distinction

Coenurus

→ Multiple protoscolices in one cyst

Cysticercus

→ Typically single invaginated scolex

This is an important parasitologic distinction.

Treatment

The primary treatment described in the source is:

Surgical removal of the cyst

whenever anatomically possible.

Surgery can provide both:

Definitive diagnosis

and

Treatment

Praziquantel

The source states that:

High-dose praziquantel (>50 mg/kg)

may also be helpful.

Because human coenurosis is exceptionally rare, evidence for antiparasitic treatment is limited and management depends heavily on cyst location and surgical feasibility.

Treatment Principle

Localized accessible coenurus cyst

↓

Surgical excision when feasible

• ●

Histopathologic confirmation

↓

Consider antiparasitic therapy in selected cases

Prevention

Prevention focuses on interrupting fecal–oral transmission from dogs and other canids.

Important measures include:

• Handwashing after handling dogs

• Avoiding food or water contaminated with dog feces

• Appropriate disposal of dog feces

• Veterinary parasite control and deworming

• Preventing dogs from consuming infected animal tissues

High-Yield Clinical Pattern

Rare cestode infection

• ●

Dog is the definitive host

• ●

Human ingests eggs from dog feces

• ●

CNS cyst containing multiple protoscolices

→ Think Multiceps multiceps (Taenia multiceps)

→ Coenurosis

Exam Essentials

Organism: Multiceps multiceps

Alternative classification: Taenia multiceps

Type: Cestode (tapeworm)

Definitive host: Dogs and other canids

Human role: Accidental intermediate host

Transmission to humans: Ingestion of eggs from dog fecal contamination

Distribution: Worldwide

Human infection: Very rare

Disease: Coenurosis

Larval lesion: Coenurus cyst

Characteristic morphology: Multiple protoscolices within a cyst

Important site: Central nervous system

Other sites: Eye, subcutaneous tissue, and other tissues

Diagnosis: Histopathology of excised tissue; imaging assists localization

Main treatment: Surgical removal when possible

Source additional treatment: High-dose praziquantel may help

Prevention: Hygiene, avoidance of dog-fecal contamination, and veterinary parasite control

Key clinical pearl: Multiceps multiceps (Taenia multiceps) is a rare dog-associated cestode that causes human coenurosis after accidental ingestion of eggs from dog feces. CNS disease is particularly important, and the characteristic coenurus cyst contains multiple protoscolices—distinguishing it from the usually single-scolex cysticercus of Taenia solium.

Infectious Disease and Microbiology – Morganella morganii

Overview

Morganella morganii is an aerobic Gram-negative bacillus in the Enterobacterales group that is widely distributed and most often causes opportunistic healthcare-associated infections.

It is particularly associated with urinary tract infection, pneumonia, bacteremia, and sepsis, especially in hospitalized or medically complex patients. It may also be present in the mouths of snakes and can occasionally contribute to infection after snake bites.

⸻

Classification

Genus: Morganella

Species: Morganella morganii

Type: Aerobic Gram-negative bacillus

Order: Enterobacterales

⸻

Microbiologic Characteristics

M. morganii is generally:

• Gram-negative

• Rod-shaped

• Facultatively anaerobic despite the source describing it as aerobic

• Motile

• A member of the normal intestinal flora in humans and animals

It is related microbiologically to organisms such as:

• Proteus

• Providencia

⸻

Incubation Period

The incubation period is:

Unknown

Because most infections are endogenous or healthcare-associated, a specific incubation period is usually not defined.

⸻

Epidemiology

Morganella morganii occurs:

Worldwide

It is generally a low-virulence organism but can become pathogenic in the presence of:

• Hospitalization

• Indwelling urinary catheters

• Advanced age

• Immunosuppression

• Recent surgery

• Broad-spectrum antibiotic exposure

• Other severe underlying illness

⸻

Nosocomial Infection

The source emphasizes that M. morganii most commonly causes:

Healthcare-associated infection

Important sites include:

• Urinary tract

• Respiratory tract

• Bloodstream

• Wounds

⸻

Urinary Tract Infection

One of the most common clinical manifestations is:

Urinary tract infection

This is especially associated with:

• Urinary catheterization

• Structural urinary tract disease

• Prolonged hospitalization

⸻

Urease Production

M. morganii is:

Urease positive

This can contribute to:

Alkaline urine

and may promote urinary crystal or stone formation in some patients.

⸻

High-Yield Urinary Pattern

Hospitalized patient

Urinary catheter

Gram-negative bacillus

Urease positivity

→ Consider Morganella morganii, Proteus, or Providencia

⸻

Pulmonary Infection

M. morganii may cause:

Pneumonia

particularly in:

• Hospitalized patients

• Patients with chronic illness

• Ventilated patients

• Immunocompromised hosts

Pulmonary infection is usually healthcare-associated rather than community-acquired.

⸻

Bacteremia and Sepsis

M. morganii can enter the bloodstream and cause:

Bacteremia

or

Sepsis

Common sources include:

• Urinary tract

• Intra-abdominal infection

• Wounds

• Respiratory tract

Severe infection is more likely in medically fragile patients.

⸻

Snake Bite-Associated Infection

The source notes that M. morganii may be found in:

Snake oral flora

Therefore, it can occasionally contribute to:

Secondary infection of snake bite wounds

These infections are often polymicrobial.

⸻

Clinical Implication

After a snake bite, wound infection may involve:

• Morganella

• Aeromonas

• Enteric Gram-negative bacilli

• Anaerobic organisms

The exact microbiology depends on the snake species and environmental exposure.

⸻

Diagnosis

The primary diagnostic method is:

Culture

Relevant specimens may include:

• Urine

• Blood

• Respiratory secretions

• Wound material

• Other normally sterile body fluids

⸻

Laboratory Identification

M. morganii may be identified using:

• Routine biochemical testing

• Automated microbiology systems

• MALDI-TOF mass spectrometry

Susceptibility testing is particularly important because resistance patterns can vary.

⸻

Antibiotic Resistance

An important feature of M. morganii is the presence of:

Chromosomal AmpC beta-lactamase

This can confer resistance to several beta-lactam antibiotics and may lead to resistance emerging during therapy.

⸻

AmpC Clinical Significance

AmpC activity may reduce susceptibility to:

• Ampicillin

• Amoxicillin

• First-generation cephalosporins

• Some later-generation cephalosporins

For serious infection, treatment should be based on:

Antimicrobial susceptibility results

⸻

High-Yield Resistance Pattern

Morganella morganii

Enterobacterales organism

AmpC beta-lactamase potential

→ Be cautious with cephalosporins in serious infections

⸻

Treatment

The source lists:

• Carbapenems, including imipenem and meropenem

• Ciprofloxacin

These may be appropriate for susceptible isolates, especially in severe infection.

⸻

Additional Treatment Options

The source also lists:

• Third-generation cephalosporins

• Aztreonam

• Ofloxacin

• Piperacillin–tazobactam

• Aminoglycosides

However, resistance is increasingly important, so therapy should be:

Susceptibility guided

⸻

Third-Generation Cephalosporins

The source specifically notes:

Increasing resistance

with third-generation cephalosporins.

Because inducible or derepressed AmpC beta-lactamase activity can occur, these drugs may be unreliable in some serious infections.

⸻

Treatment Principle

Severe M. morganii infection

↓

Obtain cultures

↓

Perform susceptibility testing

↓

Select active antimicrobial therapy

↓

Address source control

This may include:

• Removing infected catheters

• Draining abscesses

• Managing obstructed urinary systems

• Debriding infected wounds when necessary

⸻

Morganella vs. Proteus

Morganella morganii

→ Gram-negative rod

→ Urease positive

→ Nosocomial UTI and sepsis

→ Motile

→ AmpC beta-lactamase potential

→ Does not typically produce the dramatic swarming pattern associated with Proteus

Proteus mirabilis

→ Gram-negative rod

→ Strongly urease positive

→ Swarming motility

→ UTI and struvite stones

→ Characteristic fishy odor may occur

⸻

Morganella vs. Providencia

Morganella

→ Healthcare-associated UTI

→ Sepsis

→ Urease positive

→ AmpC-associated resistance

Providencia

→ Particularly associated with long-term urinary catheters

→ UTI and bacteremia

→ Often multidrug resistant

Both belong to the Proteeae group and may have overlapping clinical settings.

⸻

High-Yield Clinical Pattern

Hospitalized or catheterized patient

UTI, pneumonia, or sepsis

Gram-negative bacillus

Urease positive

Potential AmpC resistance

→ Think Morganella morganii

⸻

Exam Essentials

Genus: Morganella

Species: M. morganii

Type: Gram-negative bacillus

Order: Enterobacterales

Motility: Motile

Urease: Positive

Distribution: Worldwide

Typical setting: Nosocomial/opportunistic infection

Major infections: UTI, pneumonia, bacteremia, sepsis

Special exposure: Snake bite wounds

Diagnosis: Culture

Resistance mechanism: Chromosomal AmpC beta-lactamase

Source treatment: Carbapenem or ciprofloxacin

Other options: Piperacillin–tazobactam, aztreonam, fluoroquinolones, aminoglycosides, selected cephalosporins

Treatment principle: Use susceptibility-guided therapy, particularly for severe infection

⸻

Key clinical pearl: Morganella morganii is a urease-positive opportunistic Gram-negative rod that commonly causes healthcare-associated UTI and sepsis. Its ability to express AmpC beta-lactamase makes resistance an important treatment consideration, so serious infections should be managed with susceptibility-guided therapy and appropriate source control.

Infectious Disease and Microbiology – Moraxella (Branhamella) Species

Overview

Moraxella species are aerobic Gram-negative coccobacilli that commonly colonize the human upper respiratory tract and can cause a variety of infections. The most clinically important species is Moraxella catarrhalis, formerly called Branhamella catarrhalis.

These organisms are especially associated with otitis media, sinusitis, bronchitis, and pneumonia, and they may also cause conjunctivitis, bacteremia, endocarditis, and arthritis.

Classification

Genus: Moraxella

Important species:

• M. atlantae

• M. catarrhalis

• M. lacunata

• M. nonliquefaciens

• M. osloensis

• M. phenylpyruvica

Type: Aerobic Gram-negative coccobacillus

Historical Name

Moraxella catarrhalis was historically classified as:

Branhamella catarrhalis

Older literature may therefore refer to the organism as:

Branhamella

Microbiologic Characteristics

Moraxella species are generally:

• Aerobic

• Gram-negative

• Coccobacillary in appearance

• Part of the normal respiratory/oral flora

M. catarrhalis is often described microscopically as a Gram-negative diplococcus, which can resemble Neisseria species.

Incubation Period

The incubation period is:

Unknown

Because many Moraxella infections arise from organisms already colonizing the upper respiratory tract, there is usually no clearly defined incubation period.

Epidemiology

M. catarrhalis is a:

Common human respiratory pathogen

Moraxella species may also exist as normal flora of the:

• Oropharynx

• Upper respiratory tract

• Oral cavity

Colonization is particularly common in children.

Major Risk Groups

Clinically significant disease occurs commonly in:

• Young children

• Older adults

• Patients with chronic pulmonary disease

• Patients with COPD

• Immunocompromised individuals

M. catarrhalis is particularly important in respiratory exacerbations among patients with chronic lung disease.

Otitis Media

M. catarrhalis is an important cause of:

Acute otitis media

especially in children.

It is one of the classic bacterial causes together with:

• Streptococcus pneumoniae

• Nontypeable Haemophilus influenzae

• Moraxella catarrhalis

High-Yield Otitis Pattern

Child with acute otitis media

→ Think of:

S. pneumoniae

• ●

H. influenzae

• ●

M. catarrhalis

Sinusitis

M. catarrhalis is also a recognized cause of:

Acute bacterial sinusitis

particularly in children.

Clinical manifestations can include:

• Nasal congestion

• Purulent nasal discharge

• Facial pain or pressure

• Fever

Lower Respiratory Tract Infection

Moraxella, particularly M. catarrhalis, can cause:

• Acute bronchitis

• COPD exacerbations

• Pneumonia

• Bronchopneumonia

COPD Association

One of the most important adult associations is:

Acute exacerbation of chronic obstructive pulmonary disease

M. catarrhalis commonly infects or colonizes the respiratory tract of older adults with chronic lung disease.

High-Yield COPD Pattern

Older patient with COPD

• ●

Increased cough

• ●

Purulent sputum

• ●

Respiratory exacerbation

→ Consider Moraxella catarrhalis

Laryngitis

The source also lists:

Laryngitis

among upper respiratory tract infections that may be associated with Moraxella species.

Ocular Infections

Neonatal Conjunctivitis

The source describes:

Neonatal conjunctivitis

usually associated with:

M. catarrhalis

Blepharoconjunctivitis

Several Moraxella species can cause:

Blepharoconjunctivitis

The species classically associated with this manifestation is:

Moraxella lacunata

High-Yield Eye Association

M. lacunata

→ Blepharoconjunctivitis

Invasive Disease

Although less common than respiratory disease, Moraxella species can occasionally cause:

• Bacteremia

• Endocarditis

• Septic arthritis

These manifestations are more likely in patients with significant comorbid illness or impaired immunity.

Diagnosis

The primary diagnostic method is:

Culture

Clinical specimens may include:

• Respiratory secretions

• Blood

• Conjunctival material

• Synovial fluid

Species identification can help establish the significance of unusual isolates.

Laboratory Characteristics of M. catarrhalis

M. catarrhalis is typically:

• Gram-negative

• Diplococcal/coccobacillary

• Oxidase positive

• Catalase positive

It can resemble Neisseria microscopically but has distinct biochemical characteristics.

Beta-Lactamase Production

A major therapeutic feature is that:

M. catarrhalis frequently produces beta-lactamase

This means that simple:

Ampicillin

or

Amoxicillin alone

may be ineffective.

High-Yield Resistance Pattern

Moraxella catarrhalis

• ●

Beta-lactamase production

→ Avoid relying on plain amoxicillin when resistance is suspected

→ Amoxicillin–clavulanate provides beta-lactamase protection

Treatment

The source lists:

Amoxicillin–clavulanate

as first-line treatment.

This is a logical choice because clavulanate inhibits many beta-lactamases produced by M. catarrhalis.

Additional Treatment Options

The source also lists:

• Macrolides

• Fluoroquinolones

• Second-generation cephalosporins

• Trimethoprim–sulfamethoxazole

Treatment should be chosen according to:

• Site of infection

• Severity

• Local resistance patterns

• Patient allergies

• Susceptibility results when available

Treatment Principle

Suspected M. catarrhalis infection

• ●

Frequent beta-lactamase production

↓

Choose an agent stable to or protected from beta-lactamase

Examples:

Amoxicillin–clavulanate

or another active alternative

Moraxella catarrhalis vs. Haemophilus influenzae

M. catarrhalis

→ Gram-negative diplococcus/coccobacillus

→ Otitis media

→ Sinusitis

→ COPD exacerbation

→ Frequent beta-lactamase production

Nontypeable H. influenzae

→ Small Gram-negative coccobacillus

→ Otitis media

→ Sinusitis

→ COPD exacerbation

→ Also commonly produces beta-lactamase

Both are major respiratory pathogens.

Moraxella catarrhalis vs. Neisseria

Moraxella catarrhalis

→ Gram-negative diplococcus

→ Respiratory tract pathogen

→ Otitis, sinusitis, COPD exacerbation

→ Usually noninvasive

Neisseria meningitidis

→ Gram-negative diplococcus

→ Meningitis

→ Meningococcemia

Neisseria gonorrhoeae

→ Gram-negative diplococcus

→ Gonorrhea

→ Pelvic inflammatory disease

→ Neonatal conjunctivitis

High-Yield Clinical Pattern

Child with otitis media or sinusitis

or

Older patient with COPD exacerbation

• ●

Gram-negative diplococcus/coccobacillus

• ●

Frequent beta-lactamase production

→ Think Moraxella catarrhalis

Exam Essentials

Genus: Moraxella

Former genus/name: Branhamella

Major species: M. catarrhalis

Type: Aerobic Gram-negative coccobacillus/diplococcus

Normal habitat: Upper respiratory/oral flora

Major infections: Otitis media, sinusitis, bronchitis, COPD exacerbation, pneumonia

Eye association: M. lacunata → blepharoconjunctivitis

Other infections: Bacteremia, endocarditis, arthritis

Diagnosis: Culture

Important resistance mechanism: Beta-lactamase production

Source treatment: Amoxicillin–clavulanate

Alternatives: Macrolide, fluoroquinolone, second-generation cephalosporin, TMP-SMX

Key clinical pearl: Moraxella catarrhalis is a common respiratory pathogen, especially in children with otitis/sinusitis and adults with COPD exacerbations. Because it frequently produces beta-lactamase, amoxicillin–clavulanate is a classic treatment choice.

Infectious Disease and Microbiology – Molluscum Contagiosum Virus

Overview

Molluscum contagiosum virus (MCV) is a double-stranded DNA poxvirus that causes molluscum contagiosum, a common superficial skin infection characterized by small, firm, pearly or waxy papules with central umbilication.

The infection occurs worldwide and spreads through direct skin-to-skin contact, sexual contact, autoinoculation, and contaminated fomites. Disease is usually mild and self-limited in immunocompetent individuals but may become extensive in patients with significant immunodeficiency.

Classification

Family: Poxviridae

Genus: Molluscipoxvirus

Virus: Molluscum contagiosum virus

Genome: Double-stranded DNA

Symmetry: Complex

Host: Humans

Microbiologic Characteristics

Molluscum contagiosum virus is:

• Enveloped

• Double-stranded DNA virus

• Large and structurally complex

• A member of the poxvirus family

Like other poxviruses, MCV is unusual among DNA viruses because its replication occurs primarily in the:

Cytoplasm

rather than the nucleus.

Incubation Period

The incubation period is typically:

2–7 weeks

However, it may occasionally extend for as long as:

6 months

Epidemiology

Molluscum contagiosum has a:

Worldwide distribution

Humans are the natural reservoir and source of infection.

It is particularly common among:

• Children

• Sexually active adults

• Individuals with close skin-to-skin exposure

• Patients with impaired cellular immunity

Transmission

Transmission occurs through:

• Direct skin-to-skin contact

• Sexual contact

• Contaminated fomites

• Shared towels or personal items

• Autoinoculation

Autoinoculation can spread lesions from one part of the patient’s body to another, particularly after scratching.

Clinical Infection

The characteristic lesion is a:

Discrete, dome-shaped, waxy or pearly papule with central umbilication

The source describes most patients as having approximately:

2–20 lesions

although the number can vary substantially.

Appearance of Lesions

Typical lesions are:

• Firm

• Smooth

• Flesh-colored, pearly, or waxy

• Dome-shaped

• Usually painless

• Centrally umbilicated

The central depression is one of the most recognizable features of molluscum contagiosum.

High-Yield Lesion Pattern

Small pearly papule

• ●

Smooth dome-shaped surface

• ●

Central umbilication

→ Think molluscum contagiosum

Distribution

In children, lesions commonly occur on:

• Trunk

• Extremities

• Face

• Skin folds

In adults, sexually transmitted infection may produce lesions around the:

• Genital region

• Lower abdomen

• Inner thighs

• Perineum

Autoinoculation

Patients may spread the virus to adjacent areas through:

Scratching or manipulation of lesions

This can result in multiple lesions appearing in a linear or clustered distribution.

Molluscum Contagiosum in Immunocompromised Patients

Patients with substantial immunodeficiency, including advanced HIV infection, may develop:

• Numerous lesions

• Larger lesions

• Giant lesions

• Confluent lesions

• Extensive skin involvement

• Persistent or treatment-resistant disease

Facial involvement can be particularly prominent in advanced immunosuppression.

High-Yield Immunodeficiency Pattern

Numerous large or giant umbilicated papules

• ●

Extensive or unusual distribution

→ Consider significant immunodeficiency

In the appropriate clinical context, extensive molluscum contagiosum should prompt consideration of impaired cellular immunity.

Diagnosis

Diagnosis is usually:

Clinical

The characteristic centrally umbilicated papules are generally sufficient for diagnosis.

Histopathology

When the diagnosis is uncertain, biopsy can demonstrate characteristic intracytoplasmic inclusion bodies known as:

Henderson–Patterson bodies

or:

Molluscum bodies

These represent large viral inclusion bodies within infected epidermal cells.

High-Yield Pathology

Umbilicated papules

• ●

Large eosinophilic intracytoplasmic Henderson–Patterson bodies

→ Molluscum contagiosum

Electron Microscopy

The source also lists:

Electron microscopy

which can demonstrate characteristic poxvirus particles.

However, electron microscopy is generally unnecessary for routine clinical diagnosis.

Differential Diagnosis

In immunocompromised patients, molluscum-like lesions can resemble disseminated fungal infections, particularly:

Cryptococcus

and

Histoplasma

Both can produce umbilicated papules, especially in patients with advanced immunodeficiency.

Important Diagnostic Warning

Immunocompromised patient

• ●

Umbilicated skin lesions

does not automatically mean molluscum contagiosum.

Consider:

• Molluscum contagiosum

• Disseminated cryptococcosis

• Disseminated histoplasmosis

Biopsy may be necessary when the presentation is atypical.

Natural Course

In immunocompetent patients, molluscum contagiosum is generally:

Self-limited

Individual lesions may resolve spontaneously, although complete clearance of all lesions can take considerably longer than the 2–4 months described in the source.

Therefore, uncomplicated disease can often be managed with:

Observation

when treatment is not otherwise necessary.

Treatment

Treatment is not always required in immunocompetent patients because spontaneous resolution is common.

Treatment may be considered when lesions are:

• Symptomatic

• Numerous

• Cosmetically troublesome

• Persistently spreading

• Located in problematic areas

• Associated with significant transmission concerns

Cryotherapy

Lesions can be destroyed using:

Liquid nitrogen cryotherapy

This is an effective physical treatment but may cause discomfort, blistering, or pigmentary changes.

Curettage

Another treatment is:

Curettage

which physically removes individual lesions.

This can be effective when relatively few lesions are present.

Cantharidin

The source lists topical:

Cantharidin

which produces controlled blistering and destruction of treated lesions.

It is an established treatment option for selected patients.

Other Topical Therapy

The source also lists keratolytic or peeling preparations such as:

Salicylic acid

These agents may help remove superficial lesions in selected circumstances.

Treatment in Immunocompromised Patients

In patients with HIV-associated immunodeficiency, an important component of management is:

Immune reconstitution with effective antiretroviral therapy

Improvement in cellular immunity may lead to substantial regression of extensive molluscum lesions.

Treatment Principle

Immunocompetent patient

→ Often self-limited

→ Observation or local lesion-directed therapy

Immunocompromised patient

→ May have extensive/refractory lesions

→ Local treatment as appropriate

→ Restore immune function whenever possible

Prevention

Prevention focuses on reducing direct and indirect transmission.

Important measures include:

• Avoiding direct contact with active lesions

• Avoiding scratching or picking lesions

• Avoiding sharing towels or personal items

• Covering lesions when appropriate

• Avoiding sexual contact involving affected areas until appropriately evaluated/managed

Molluscum Contagiosum vs. Herpes Simplex

Molluscum contagiosum

→ Firm, pearly papules

→ Central umbilication

→ Usually painless

→ Poxvirus

Herpes simplex

→ Grouped vesicles that may ulcerate

→ Frequently painful or burning

→ Recurrence common

→ Herpesvirus

Molluscum Contagiosum vs. Cryptococcus

Molluscum contagiosum

→ Classic pearly umbilicated papules

→ Usually superficial skin infection

→ Henderson–Patterson bodies

Disseminated cryptococcosis

→ May produce molluscum-like umbilicated lesions

→ Particularly concerning in severe immunosuppression

→ Represents systemic fungal disease

Thus, atypical umbilicated lesions in a severely immunocompromised patient may warrant biopsy rather than assuming they are molluscum.

High-Yield Clinical Pattern

Child or young adult

• ●

Multiple painless, pearly/waxy papules

• ●

Central umbilication

→ Think Molluscum contagiosum virus

Exam Essentials

Virus: Molluscum contagiosum virus

Family: Poxviridae

Genus: Molluscipoxvirus

Genome: Double-stranded DNA

Envelope: Present

Symmetry: Complex

Replication: Cytoplasm

Reservoir: Humans

Transmission: Skin-to-skin contact, sexual contact, fomites, autoinoculation

Incubation: Usually 2–7 weeks, potentially longer

Classic lesion: Pearly/waxy centrally umbilicated papule

Histology: Henderson–Patterson (molluscum) bodies

Immunodeficiency: Larger, more numerous, persistent lesions

Important differential in immunocompromised patients: Cryptococcus and Histoplasma

Diagnosis: Usually clinical; biopsy if uncertain

Natural history: Usually self-limited in immunocompetent hosts

Local treatments: Cryotherapy, curettage, cantharidin, selected keratolytic therapies

HIV-associated disease: Immune reconstitution with antiretroviral therapy is important

Prevention: Avoid direct lesion contact and sharing contaminated personal items

Key clinical pearl: Molluscum contagiosum is a poxvirus infection classically producing painless, pearly, centrally umbilicated papules with Henderson–Patterson bodies on histology. Very large, numerous, or persistent lesions should raise concern for significant immunodeficiency, while molluscum-like lesions in an immunocompromised patient should also prompt consideration of disseminated cryptococcosis or histoplasmosis.

Infectious Disease and Microbiology – Mobiluncus Species

Overview

Mobiluncus species are anaerobic, curved, motile bacilli associated mainly with bacterial vaginosis (BV). The principal species are Mobiluncus curtisii and M. mulieris.

They are often found together with other organisms involved in the polymicrobial vaginal dysbiosis of BV, especially Gardnerella vaginalis. Their presence supports the diagnosis of BV but is not required for it.

Classification

Genus: Mobiluncus

Important species:

• M. curtisii

• M. mulieris

Type: Anaerobic curved bacillus

Microbiologic Characteristics

Mobiluncus species are:

• Anaerobic

• Curved bacilli

• Motile

• Often Gram-variable

They may appear Gram-negative on staining, but their cell-wall structure is more consistent with Gram-positive organisms.

This Gram-variable appearance can make identification challenging.

Incubation Period

The incubation period is:

Unknown

Because Mobiluncus is part of a polymicrobial alteration of vaginal flora rather than a classic single-pathogen infection, a precise incubation period is not generally defined.

Epidemiology

Mobiluncus organisms are strongly associated with:

Bacterial vaginosis

The source reports that Mobiluncus can be isolated from vaginal specimens in:

More than 50% of women with BV

compared with approximately:

5% of women without BV

This indicates a strong association, although Mobiluncus alone does not define the disease.

Bacterial Vaginosis

BV is best understood as:

Vaginal dysbiosis

rather than infection caused by a single bacterium.

There is a reduction in protective:

Lactobacillus

species and an increase in anaerobic or facultative organisms such as:

• Gardnerella vaginalis

• Mobiluncus species

• Other anaerobic bacteria

Role of Mobiluncus

Mobiluncus is commonly found in BV but generally acts as part of a:

Polymicrobial microbial community

rather than as an isolated primary pathogen.

Thus:

Mobiluncus present

does not necessarily mean:

Mobiluncus alone caused the vaginal symptoms

Clinical Manifestations

Clinical manifestations are primarily those of:

Bacterial vaginosis

Typical features include:

• Thin, homogeneous vaginal discharge

• Gray-white discharge

• Characteristic fishy odor

• Vaginal pH above 4.5

• Minimal inflammatory response

Prominent vulvar inflammation or marked pruritus is less typical of BV and should suggest alternative diagnoses.

Gardnerella Association

The source emphasizes that other organisms, particularly:

Gardnerella vaginalis

are frequently isolated together with Mobiluncus.

A useful concept is:

BV = polymicrobial dysbiosis

rather than:

BV = infection by Gardnerella alone

or:

BV = infection by Mobiluncus alone

Diagnosis

The source lists:

• Anaerobic culture

• Direct immunofluorescence of vaginal fluid

However, routine diagnosis of BV generally relies more on clinical and microscopic criteria than culture of individual organisms.

Amsel Criteria

A common clinical approach is the:

Amsel criteria

BV is supported when at least 3 of 4 findings are present:

• Thin, homogeneous vaginal discharge

• Vaginal pH >4.5

• Positive amine or whiff test

• Clue cells on microscopy

Nugent Score

Gram-stained vaginal specimens can also be evaluated using the:

Nugent scoring system

This assesses the balance among:

• Large Gram-positive Lactobacillus-type rods

• Small Gram-variable rods such as Gardnerella

• Curved Gram-variable rods consistent with Mobiluncus

Thus, curved Mobiluncus-like organisms on Gram stain can contribute to the microscopic diagnosis of BV.

High-Yield Microscopic Clue

Curved Gram-variable rods

• ●

Reduced Lactobacillus

• ●

Clue cells

→ Support bacterial vaginosis

Culture

Anaerobic culture can grow Mobiluncus, but culture is generally not required for routine diagnosis of BV.

This is because Mobiluncus can occasionally be present in women without BV, and BV is defined by the overall alteration in vaginal microbiota.

Treatment

The source lists:

Penicillin

as a treatment directed against Mobiluncus.

It also lists:

Amoxicillin–clavulanate

as an alternative.

However, when Mobiluncus is detected in the setting of BV, treatment should target:

Bacterial vaginosis as a syndrome

rather than one organism in isolation.

Metronidazole

The source correctly emphasizes:

Metronidazole is the drug of choice for bacterial vaginosis regardless of whether Mobiluncus is detected.

This is the most important therapeutic principle.

Other BV Therapy

Another commonly used treatment for BV is:

Clindamycin

which provides activity against many of the anaerobic organisms involved in vaginal dysbiosis.

Treatment Principle

Patient with bacterial vaginosis

• ●

Mobiluncus detected or not detected

↓

Treat the BV syndrome

↓

Metronidazole or another recommended BV regimen

The presence of Mobiluncus does not normally require a completely separate treatment strategy.

Mobiluncus vs. Gardnerella vaginalis

Mobiluncus

→ Curved, motile anaerobic bacillus

→ Gram-variable

→ Strongly associated with BV

→ Often seen as curved rods on Gram stain

Gardnerella vaginalis

→ Small pleomorphic Gram-variable coccobacillus

→ Frequently associated with BV

→ Important contributor to clue-cell formation and vaginal biofilm

Both are part of the broader polymicrobial process.

Bacterial Vaginosis vs. Candida Vaginitis

Bacterial vaginosis

→ Thin homogeneous discharge

→ Fishy odor

→ pH >4.5

→ Clue cells

→ Usually little inflammation

→ Gardnerella and anaerobes including Mobiluncus

Vulvovaginal candidiasis

→ Thick white discharge

→ Prominent pruritus/inflammation

→ Usually normal vaginal pH

→ Budding yeast or pseudohyphae

High-Yield Clinical Pattern

Thin gray-white vaginal discharge

• ●

Fishy odor

• ●

Vaginal pH >4.5

• ●

Clue cells

• ●

Curved Gram-variable rods

→ Think bacterial vaginosis with Mobiluncus species as part of the polymicrobial flora

Exam Essentials

Genus: Mobiluncus

Important species: M. curtisii, M. mulieris

Type: Anaerobic curved bacillus

Motility: Motile

Gram stain: Frequently Gram-variable

Major association: Bacterial vaginosis

Other major organism in BV: Gardnerella vaginalis

Clinical concept: BV is polymicrobial dysbiosis

Microscopic clue: Curved Gram-variable rods

BV diagnosis: Amsel criteria or Nugent scoring

Source organism-directed treatment: Penicillin

Additional source treatment: Amoxicillin–clavulanate

Most important BV treatment principle: Metronidazole treats bacterial vaginosis regardless of whether Mobiluncus is detected

Key clinical pearl: Mobiluncus species are curved, motile, Gram-variable anaerobic bacilli strongly associated with bacterial vaginosis. Their presence supports BV, but BV is a polymicrobial dysbiosis, so treatment is directed at the syndrome—classically with metronidazole—rather than at Mobiluncus alone.

Microbiology - Microsporum Species

Microsporum is a genus of filamentous fungi (molds) that belongs to the dermatophyte group. Important species include Microsporum audouinii and Microsporum canis, along with several other species. These fungi mainly infect keratinized tissues, particularly the skin and hair, although nail infection may occasionally occur.

Microsporum infections occur worldwide. Some species are associated with animals; for example, M. canis is commonly linked to cats and dogs and can be transmitted to humans. The incubation period is variable and is not always clearly defined.

Microsporum can cause different forms of tinea (dermatophytosis), including tinea capitis of the scalp and hair, tinea corporis of the body, and tinea faciei of the face. Nail infection or onychomycosis is less commonly caused by Microsporum compared with other dermatophytes.

Diagnosis is made by collecting skin scrapings or infected hairs from the lesion. The fungus may then be identified using direct microscopic examination, fungal culture, or other laboratory methods.

Treatment depends on the site of infection. Localized skin infections may be treated with topical terbinafine, usually for several weeks. Tinea capitis generally requires oral antifungal therapy because topical treatment alone does not penetrate the infected hair follicles adequately. Oral agents may include griseofulvin, terbinafine, or itraconazole, depending on the organism and clinical situation.

If onychomycosis occurs, treatment is usually prolonged and may continue for several months. Itraconazole may also be used for certain dermatophyte infections, particularly when topical treatment is not sufficient.

Infectious Disease and Microbiology – Microsporidia

Overview

Microsporidia are a large group of obligate intracellular, spore-forming organisms that cause microsporidiosis. They were historically classified as protozoa, but molecular and phylogenetic evidence now places them within or very close to the fungal lineage.

Human infection is particularly important in immunocompromised patients, in whom microsporidia can cause severe chronic watery diarrhea and disseminated disease. Immunocompetent individuals may have mild disease or remain asymptomatic.

Classification

Historically, microsporidia were placed in the phylum Microspora, containing more than 100 genera and approximately 1,000 described species in the source.

Organisms of recognized or historical clinical significance include:

• Enterocytozoon bieneusi

• Encephalitozoon cuniculi

• Encephalitozoon hellem

• Nosema species

• Pleistophora species

• Vittaforma corneae

• Other microsporidia

Important Taxonomic Correction

The source lists:

Enterocytozoon cuniculi

and

Enterocytozoon hellem

These are more correctly classified as:

Encephalitozoon cuniculi

and

Encephalitozoon hellem

The source also contains several older names because the taxonomy of microsporidia has undergone substantial revision.

Microbiologic Characteristics

Microsporidia are:

• Obligate intracellular organisms

• Spore-forming

• Extremely small

• Historically classified as protozoa

• Currently considered highly specialized fungus-related organisms

They cannot complete their replicative life cycle independently outside host cells.

Spores

The environmentally resistant and infectious form is the:

Spore

Microsporidial spores are very small and contain a highly characteristic structure called the:

Polar tube

The polar tube is one of the most distinctive features of microsporidia.

Polar Tube

When an infectious spore encounters an appropriate host cell:

Spore activation

↓

Polar tube rapidly extrudes

↓

Polar tube penetrates host-cell membrane

↓

Infectious material is injected into host cell

↓

Intracellular replication

↓

New spores form

This unusual mechanism of cellular invasion is a major high-yield microbiologic feature.

Epidemiology

Microsporidia have a:

Worldwide distribution

However, many aspects of their environmental reservoirs and transmission remain incompletely understood.

Disease became particularly recognized in association with severe immunosuppression, especially during the HIV/AIDS epidemic.

Transmission

Possible routes include:

• Fecal–oral transmission

• Contaminated food or water

• Urine-associated environmental transmission

• Direct environmental exposure

The exact transmission route can vary among different microsporidial species.

Microsporidiosis

Clinical manifestations depend strongly on:

Microsporidial species

• ●

Site of infection

• ●

Host immune status

Immunocompetent individuals may remain asymptomatic, whereas immunocompromised patients can develop chronic or disseminated disease.

Gastrointestinal Disease

Chronic Watery Diarrhea

The most important gastrointestinal manifestation is:

Watery, nonbloody diarrhea

This can become severe and persistent in immunocompromised patients.

Clinical Manifestations

Intestinal microsporidiosis may produce:

• Chronic watery diarrhea

• Abdominal discomfort

• Malabsorption

• Weight loss

• Dehydration

Severe prolonged disease is especially associated with advanced immunosuppression.

Enterocytozoon bieneusi

Enterocytozoon bieneusi is an important cause of:

Intestinal microsporidiosis

It is particularly associated with:

Chronic diarrhea in immunocompromised patients

Encephalitozoon Species

Important species include:

Encephalitozoon intestinalis

Encephalitozoon cuniculi

and

Encephalitozoon hellem

These organisms can cause intestinal disease but have greater potential than E. bieneusi for infection outside the gastrointestinal tract.

Disseminated Infection

Microsporidia can spread beyond the intestine and involve:

• Biliary tract

• Respiratory tract

• Kidneys and urinary tract

• Central nervous system

• Eyes

• Muscles

• Other organs

Dissemination occurs primarily in severely immunocompromised individuals.

Biliary Disease

Microsporidiosis can involve the:

Biliary tree

and contribute to biliary inflammation or cholangitis-like disease, particularly in severely immunocompromised patients.

Pulmonary Disease

Pulmonary microsporidiosis may produce:

• Cough

• Dyspnea

• Pulmonary infiltrates

• Pneumonitis

It is primarily an opportunistic manifestation.

Central Nervous System Disease

Rarely, disseminated microsporidiosis may involve the:

Central nervous system

Neurologic manifestations depend on the location and extent of infection.

Ocular Microsporidiosis

Microsporidia can infect the:

• Conjunctiva

• Cornea

and produce:

Keratoconjunctivitis

or

Keratitis

Clinical Features

Ocular disease may cause:

• Eye redness

• Pain or irritation

• Photophobia

• Foreign-body sensation

• Blurred vision

Some ocular microsporidial infections can occur even in otherwise immunocompetent individuals.

High-Yield Ocular Pattern

Keratoconjunctivitis

• ●

Tiny intracellular spore-forming organisms

• ●

Characteristic polar tube

→ Consider microsporidiosis

Diagnosis

The source emphasizes:

Microscopic examination of stool or affected tissue

Diagnosis may involve:

• Stool examination

• Tissue biopsy

• Light microscopy

• Specialized staining

• Electron microscopy

• Molecular testing where available

Stool Examination

For intestinal disease, microsporidial spores can be detected in:

Stool specimens

Because the spores are extremely small, specialized staining and careful microscopic examination may be necessary.

Histopathology

Biopsy of affected tissue can demonstrate:

Intracellular microsporidial organisms

Histologic examination can be particularly useful in intestinal, ocular, muscular, or disseminated infection.

Electron Microscopy

Electron microscopy historically played an important role because it can demonstrate the characteristic:

Polar tube

and detailed internal architecture of the spore.

However, molecular and specialized staining techniques have reduced reliance on electron microscopy for routine diagnosis.

Molecular Diagnosis

PCR-based testing can help:

• Confirm microsporidial infection

• Identify the species

• Distinguish morphologically similar organisms

Species identification can be clinically useful because treatment response varies considerably among microsporidia.

Treatment

Albendazole

The source lists:

Albendazole

as the principal treatment.

Albendazole has useful activity against several microsporidial species, particularly:

Encephalitozoon species

Important Treatment Limitation

Treatment is species dependent.

A particularly important distinction is:

Encephalitozoon species

→ Often responsive to albendazole

whereas:

Enterocytozoon bieneusi

→ Generally responds poorly to albendazole

Therefore, identifying the causative species can influence management.

Ocular Treatment

The source describes:

Topical fumagillin preparations

as potentially effective for:

• Conjunctival microsporidiosis

• Corneal microsporidiosis

Local ophthalmologic management may also be required.

Importance of Immune Restoration

In immunocompromised patients, particularly those with HIV, improvement of immune function is a major component of management.

Effective immune restoration can substantially improve control of:

Chronic intestinal and disseminated microsporidiosis

Microsporidia in Immunocompetent vs. Immunocompromised Hosts

Immunocompetent

→ Frequently asymptomatic

→ May develop self-limited gastrointestinal disease

→ Ocular infection can occur

Immunocompromised

→ Chronic severe watery diarrhea

→ Malabsorption and weight loss

→ Biliary disease

→ Pulmonary disease

→ CNS involvement

→ Disseminated infection

High-Yield Clinical Pattern

Severely immunocompromised patient

• ●

Chronic watery, nonbloody diarrhea

• ●

Weight loss/malabsorption

• ●

Tiny intracellular spore-forming organisms in stool or intestinal tissue

→ Think Microsporidia

High-Yield Microbiology Pattern

Obligate intracellular organism

• ●

Spore formation

• ●

Unique polar tube used to inject infectious material into host cells

→ Think Microsporidia

Exam Essentials

Organisms: Microsporidia

Modern classification: Highly specialized fungus-related organisms

Historical classification: Protozoa

Lifestyle: Obligate intracellular

Infectious form: Spore

Characteristic structure: Polar tube

Transmission: Primarily fecal–oral/environmental exposure

Important species: Enterocytozoon bieneusi, Encephalitozoon intestinalis, E. cuniculi, E. hellem

Major risk group: Immunocompromised patients

Classic infection: Chronic watery, nonbloody diarrhea

Other sites: Biliary tract, lungs, CNS, urinary tract, eyes and muscle

Ocular disease: Keratitis/keratoconjunctivitis

Diagnosis: Stool or tissue microscopy, specialized stains, histology and PCR

Historical ultrastructural diagnosis: Electron microscopy

Source treatment: Albendazole

Albendazole activity: Particularly useful for Encephalitozoon species

E. bieneusi: Often poorly responsive to albendazole

Ocular treatment: Topical fumagillin may be useful

Immunocompromised patients: Immune restoration is an important component of management

Key clinical pearl: Microsporidia are tiny obligate intracellular, spore-forming, fungus-related organisms characterized by a unique polar tube. Think of them particularly in an immunocompromised patient with chronic watery nonbloody diarrhea; Encephalitozoon infections often respond to albendazole, whereas Enterocytozoon bieneusi is much less susceptible.

Infectious Disease and Microbiology – Methylobacterium Species

Overview

Methylobacterium species are aerobic Gram-negative bacilli that are widely distributed in the environment but are very rare causes of human infection. They are distinctive because many species produce characteristic pink-pigmented colonies in culture.

Human disease is usually opportunistic and occurs particularly in immunocompromised patients or in association with indwelling medical devices. Important manifestations include bacteremia and peritoneal dialysis-associated peritonitis.

Classification

Genus: Methylobacterium

Important species:

• M. extorquens

• M. mesophilicum

• Other Methylobacterium species

Type: Aerobic Gram-negative bacillus

Historical Classification

Methylobacterium species were previously classified under the genus:

Protomonas

Therefore, older microbiology literature may refer to these organisms as:

Protomonas species

Microbiologic Characteristics

Methylobacterium organisms are:

• Aerobic

• Gram-negative bacilli

• Environmental organisms

• Generally slow-growing

• Characteristically associated with pink-pigmented colonies

The pink coloration is an important laboratory clue.

Pink-Pigmented Colonies

A particularly characteristic feature of Methylobacterium is the production of:

Pink to reddish-pink colonies

For this reason, these organisms are sometimes described as:

Pink-pigmented facultative methylotrophs

The unusual pigmentation can help distinguish them from many other nonfermenting environmental Gram-negative bacilli.

Incubation Period

The incubation period is:

Unknown

Because infections are usually opportunistic and often associated with medical devices or environmental exposure, a clearly defined incubation period is generally unavailable.

Epidemiology

Human infection is:

Very rare

However, recognition of Methylobacterium infections has increased with improved microbiologic identification techniques and greater awareness of opportunistic environmental organisms.

Environmental Reservoir

Methylobacterium species are widely distributed in:

• Water

• Soil

• Plants

• Moist environmental surfaces

Their ability to persist in water-associated environments is particularly relevant to healthcare-associated infection.

Risk Factors

Invasive infection occurs primarily in patients with:

• Immunosuppression

• Malignancy

• Indwelling vascular catheters

• Peritoneal dialysis catheters

• Other implanted medical devices

Thus, isolation of Methylobacterium from a normally sterile specimen in a vulnerable patient should not automatically be dismissed as contamination.

Bacteremia

One of the most important clinical manifestations is:

Bacteremia

This is particularly associated with immunocompromised individuals and patients with intravascular devices.

Catheter-Associated Infection

Because Methylobacterium is an environmental organism with an affinity for moist environments, infection can occur in association with:

Central venous catheters

Persistent bacteremia may indicate colonization or infection of an indwelling device.

High-Yield Bacteremia Pattern

Immunocompromised patient

• ●

Indwelling vascular catheter

• ●

Gram-negative bacillus

• ●

Pink-pigmented colonies

→ Think Methylobacterium

Peritoneal Dialysis-Associated Peritonitis

Methylobacterium species may cause:

Peritonitis

in patients undergoing:

Peritoneal dialysis

The dialysis catheter provides a potential route for introduction and persistence of the organism.

Clinical Features

Peritoneal dialysis-associated infection may present with:

• Abdominal pain

• Fever

• Cloudy dialysis fluid

• Peritoneal inflammatory findings

Culture of the peritoneal dialysis fluid can establish the microbiologic diagnosis.

Opportunistic Infection

Methylobacterium is considered a:

Low-virulence opportunistic pathogen

Most clinically significant infections occur when normal host defenses are impaired or when foreign material provides a surface for persistent infection.

Colonization vs. True Infection

Because Methylobacterium is an environmental organism, a positive culture should be interpreted according to the clinical setting.

Evidence supporting true infection includes:

• Repeated positive cultures

• Isolation from a normally sterile site

• Compatible clinical illness

• Immunosuppression

• Presence of an infected catheter or device

Diagnosis

The primary diagnostic method is:

Culture

Identification is based on growth characteristics and microbiologic testing.

Laboratory Clue

A particularly useful clue is:

Pink-pigmented colonies

When an unusual aerobic Gram-negative bacillus with pink pigmentation is recovered from blood or another sterile specimen, Methylobacterium should be considered.

Modern Identification

Because unusual environmental Gram-negative bacilli can be difficult to distinguish using conventional biochemical methods, specialized identification techniques may be helpful.

These can include:

• MALDI-TOF mass spectrometry

• Molecular identification methods

Accurate species identification may be important when determining clinical significance and antimicrobial susceptibility.

Treatment

The source lists:

Trimethoprim–sulfamethoxazole (TMP-SMX)

as treatment.

Because Methylobacterium infections are uncommon and susceptibility patterns can vary, treatment should ideally be guided by:

Antimicrobial susceptibility testing

Source Control

For infections associated with:

Central venous catheters

or

Peritoneal dialysis catheters

management may require consideration of:

Catheter removal

in addition to antimicrobial therapy, particularly when infection persists.

Treatment Principle

Clinically significant Methylobacterium infection

↓

Obtain cultures and susceptibility testing

↓

Administer an active antimicrobial

• ●

Evaluate infected catheter/device

↓

Remove or replace device when necessary

Prevention

Because these organisms are environmental and associated with water and moist surfaces, prevention in healthcare settings depends on:

• Appropriate catheter care

• Aseptic technique

• Proper handling of dialysis equipment

• Prevention of contamination of medical fluids and devices

• Appropriate infection-control practices

Methylobacterium vs. Pseudomonas

Methylobacterium

→ Aerobic Gram-negative bacillus

→ Environmental organism

→ Pink-pigmented colonies

→ Rare opportunistic infection

→ Catheter-associated bacteremia and peritonitis

Pseudomonas aeruginosa

→ Aerobic Gram-negative bacillus

→ Common opportunistic pathogen

→ Blue-green pigments may occur

→ Pneumonia, bacteremia, UTI, wound infection, and device-associated infection

The distinctive pink pigmentation is an important clue favoring Methylobacterium.

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Central venous or peritoneal dialysis catheter

• ●

Bacteremia or peritonitis

• ●

Pink-pigmented aerobic Gram-negative bacillus

→ Think Methylobacterium species

Exam Essentials

Genus: Methylobacterium

Important species: M. extorquens, M. mesophilicum

Older name: Protomonas species

Type: Aerobic Gram-negative bacillus

Characteristic culture finding: Pink-pigmented colonies

Distribution: Environmental; associated with soil, plants, and water

Frequency of human infection: Very rare

Major risk group: Immunocompromised patients

Important device association: Vascular and peritoneal dialysis catheters

Major infections: Bacteremia and peritonitis

Diagnosis: Culture

Source treatment: Trimethoprim–sulfamethoxazole

ADDITIONAL TREATMENT • Ciprofloxacin • Aminoglycoside

Treatment principle: Susceptibility-guided antimicrobial therapy plus appropriate device/source control

Key clinical pearl: Methylobacterium is a rare opportunistic aerobic Gram-negative bacillus distinguished by its characteristic pink-pigmented colonies. Think of it when an immunocompromised patient with an indwelling catheter develops otherwise unexplained bacteremia or peritoneal dialysis-associated peritonitis.